Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase III Randomized, Controlled, Superiority Study Evaluating EVARREST® Fibrin Sealant Patch Versus Standard of Care Treatment in Controlling Parenchymal Bleeding During Hepatic Surgery

NCT01993888 is registered in ClinicalTrials.gov with Ethicon, Inc. as lead sponsor.

NCT NCT01993888
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01993888 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase III Randomized, Controlled, Superiority Study Evaluating EVARREST® Fibrin Sealant Patch Versus Standard of Care Treatment in Controlling Parenchymal Bleeding During Hepatic Surgery
Lead sponsor
Ethicon, Inc.
Phase
Phase 3
Overall status
Completed
Start date
October 31, 2013
Completion date
September 30, 2014
Enrollment
102 (actual)
Sites
17

Conditions

As the registry lists them; a condition with its own page is linked.

hemorrhage